549 related articles for article (PubMed ID: 9554260)
1. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
2. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
[TBL] [Abstract][Full Text] [Related]
5. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
Kipper MJ; Wilson JH; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res A; 2006 Mar; 76(4):798-810. PubMed ID: 16345084
[TBL] [Abstract][Full Text] [Related]
6. [Controlled release antigen from the injection site--new model for a single-shot vaccination?].
Gałazka A; Wysokińska T
Postepy Hig Med Dosw; 1998; 52(2):157-72. PubMed ID: 9640979
[TBL] [Abstract][Full Text] [Related]
7. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
8. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulation of antigens using biodegradable polyesters: facts and phantasies.
Kissel T; Koneberg R; Hilbert AK; Hungerer KD
Behring Inst Mitt; 1997 Feb; (98):172-83. PubMed ID: 9382738
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
Walker KB; Xing DK; Sesardic D; Corbel MJ
Dev Biol Stand; 1998; 92():259-67. PubMed ID: 9554281
[TBL] [Abstract][Full Text] [Related]
11. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
12. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP
Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205
[TBL] [Abstract][Full Text] [Related]
13. New advances in vaccine delivery systems.
Eldridge JH; Staas JK; Chen D; Marx PA; Tice TR; Gilley RM
Semin Hematol; 1993 Oct; 30(4 Suppl 4):16-24; discussion 25. PubMed ID: 8303306
[TBL] [Abstract][Full Text] [Related]
14. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.
Gupta RK; Singh M; O'Hagan DT
Adv Drug Deliv Rev; 1998 Jul; 32(3):225-246. PubMed ID: 10837646
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
16. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
Eratalay A; Coşkun-Ari FF; Oner F; Ozcengīz E
J Microencapsul; 2010; 27(1):48-56. PubMed ID: 19545223
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
[TBL] [Abstract][Full Text] [Related]
20. Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.
Peyre M; Audran R; Estevez F; Corradin G; Gander B; Sesardic D; Johansen P
J Control Release; 2004 Oct; 99(3):345-55. PubMed ID: 15451593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
